Press Release

Parkinson’s Disease Drugs Market 2026 Global Industry Share, Future Growth, Trends, Overview and Forecast 2026

The global Parkinson’s disease drugs market is likely to grow in the coming years due to the growing emphasis on the treatment of Parkinson’s disease. According to a report published by Fortune Business Insights, titled “Parkinson’s Disease Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 4,500.0 Mn in 2018. Fortune Business Insights states that the market will reach US$ 8,383.2 Mn by 2026, thereby exhibiting a CAGR of 8.1%.

 

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/parkinson-s-disease-drugs-market-100655

 

Increasing usage approvals are contributing to the growth of the global Parkinson’s disease drugs market. The Food and Drug Administration recently cleared two new drugs for the treatment of Parkinson’s disease. The drug approvals for Rytary and Duopa will emerge as breakthroughs in the healthcare industry.

Leading Players operating in the Parkinson’s Disease Drugs Market are:

 

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

 

  • Pfizer, Inc.
  • Hoffmann-La Roche Ltd
  • Merck & Co., Inc.
  • Novartis
  • Orion Pharma Ltd
  • UCB S.A
  • Teva Pharmaceutical Industries Ltd.
  • Vertical Pharmaceuticals, LLC
  • ACADIA Pharmaceuticals Inc.
  • Impax Laboratories, Inc.
  • Lundbeck A/S.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/parkinson-s-disease-drugs-market-100655

Detailed Table of Content:

 

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Market Trends
  • Key Insights
    • Prevalence of Parkinson’s Disease – For Key Countreis, 2018
    • Regulatory Scenario – For Key Countries
    • Patent Snapshot
    • New Product Launch
    • Pipeline Analysis
    • Key Industry Developments – Mergers, Acquisitions and Partnerships
  • Global Parkinson’s Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • Decarboxylase Inhibitors
      • Dopamine Agonists
      • Monoamine Oxidase Type B (MAO-B) Inhibitors
      • Catechol-O-Methyltransferase (COMT) Inhibitors
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Injection
      • Transdermal
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacy
      • Retail Pharmacy
      • Online Stores
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
    • North America Parkinson’s Disease Drugs Market Analysis, Insights and Forecast, 2014-2025
      • Key Findings / Summary
      • Market Analysis – By Drug Class
        • Decarboxylase Inhibitors
        • Dopamine Agonists
        • Monoamine Oxidase Type B (MAO-B) Inhibitors
        • Catechol-O-Methyltransferase (COMT) Inhibitors
        • Others
      • Market Analysis – By Route of Administration
        • Oral
        • Injection
        • Transdermal
      • Market Analysis – By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Stores
      • Market Analysis – By Country
        • S.
        • Canada

KEY QUESTIONS ANSWERED:

 

  • What are the key technological and Parkinson’s Disease Drugs Market trends shaping the market?
  • What are the key opportunities in the market?
  • What are the key companies operating in the market?
  • Which company accounted for the highest market share?
  • Why Choose Fortune Business Insights?
  • What is the market size and growth rate of the global and regional market by various segments?
  • What is the market size and growth rate of the market for selective countries?
  • Which region or sub-segment is expected to drive the market in the forecast period?
  • What Factors are estimated to drive and restrain the Parkinson’s Disease Drugs Market growth?

Related Reports:

Radiation Therapy Market- What will be the Short-term Impact of Coronavirus?               

Pemphigus Vulgaris (PV) Treatment Market: Is Covid19 testing the healthcare industry?

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close